@article{ae53156596be40188ce5c49d63a1a61d,
title = "Using imaging to combat a pandemic: rationale for developing the UK National COVID-19 Chest Imaging Database",
author = "Joseph Jacob and Daniel Alexander and Baillie, {J. Kenneth} and Rosalind Berka and Ottavia Bertolli and James Blackwood and Iain Buchan and Claire Bloomfield and Dominic Cushnan and Annemarie Docherty and Anthony Edey and Alberto Favaro and Fergus Gleeson and Mark Halling-Brown and Samanjit Hare and Emily Jefferson and Annette Johnstone and Myles Kirby and Ruth Mcstay and Arjun Nair and Openshaw, {Peter J. M.} and Geoff Parker and Gerry Reilly and Graham Robinson and Giles Roditi and Rodrigues, {Jonathan C. L.} and Neil Sebire and Semple, {Malcolm G.} and Catherine Sudlow and Nick Woznitza and Indra Joshi",
note = "Funding Information: Conflict of interest: J. Jacob reports fees from Boehringer Ingelheim and Roche unrelated to the current submission and is supported by a Clinical Research Career Development Fellowship 209553/Z/17/Z from the Wellcome Trust, and by the NIHR Biomedical Research Centre at University College London. D. Alexander has nothing to disclose. J.K. Baillie reports grants from DHSC National Institute of Health Research UK, Medical Research Council UK, Wellcome Trust, Fiona Elizabeth Agnew Trust, Intensive Care Society and Chief Scientist Office, during the conduct of the study. R. Berka is an Associate at Faculty; Faculty has a paid partnership with NHSX to build its new AI lab to help drive digital transformation and the use of AI in the NHS. This contract has been extended for setting up the platform environment that manages the data storage for the National COVID-19 Chest Imaging Database (NCCID); the platform is being made available by Faculty at zero licence cost. In addition, Faculty is contracted to support NHS England and Improvement as well as NHSX with its data response strategy to COVID-19, which includes developing dashboards, models and simulations to provide information to central government decision-makers. O. Bertolli is an Associate at Faculty; Faculty has a paid partnership with NHSX to build its new AI lab to help drive digital transformation and the use of AI in the NHS. This contract has been extended for setting up the platform environment that manages the data storage for the National COVID-19 Chest Imaging Database (NCCID); the platform is being made available by Faculty at zero licence cost. In addition, Faculty is contracted to support NHS England and Improvement as well as NHSX with its data response strategy to COVID-19, which includes developing dashboards, models and simulations to provide information to central government decision-makers. J. Blackwood has nothing to disclose. I. Buchan reports personal fees from and acting as advisor for AstraZeneca, grants from NIHR, and is a former employee of Microsoft, outside the submitted work. C. Bloomfield reports that NCIMI is funded through support from the Industry Strategy Challenge Fund, by Innovate UK grant 104688. D. Cushnan has nothing to disclose. A. Docherty has nothing to disclose. A. Edey has nothing to disclose. A. Favaro is a Lead Data Scientist at Faculty; Faculty has a paid partnership with NHSX to build its new AI lab to help drive digital transformation and the use of AI in the NHS. This contract has been extended for setting up the platform environment that manages the data storage for the National COVID-19 Chest Imaging Database (NCCID); the platform is being made available by Faculty at zero licence cost. In addition, Faculty is contracted to support NHS England and Improvement as well as NHSX with its data response strategy to COVID-19, which includes developing dashboards, models and simulations to provide information to central government decision-makers. F. Gleeson has nothing to disclose. M. Halling-Brown is an advisor to Google Health on the MAMMOTH project, and has a Visiting Professorship with University of Surrey as part of a research collaboration with Transpara. S. Hare has nothing to disclose. E. Jefferson reports grants from Medical Research Council (MRC), Health Data Research (HDR) UK, National Institute of Health Research (NIHR), Chief Scientist Office (CSO), Engineering and Physical Sciences Research Council (EPSRC), Health Foundation, Data Lab, Scottish Government, NHS Fife Health Board and EU Horizon 2020, during the conduct of the study. A. Johnstone has nothing to disclose. M. Kirby is a Principal at Faculty; Faculty has a paid partnership with NHSX to build its new AI lab to help drive digital transformation and the use of AI in the NHS. This contract has been extended for setting up the platform environment that manages the data storage for the National COVID-19 Chest Imaging Database (NCCID); the platform is being made available by Faculty at zero licence cost. In addition, Faculty is contracted to support NHS England and Improvement as well as NHSX with its data response strategy to COVID-19, which includes developing dashboards, models and simulations to provide information to central government decision-makers. R. McStay has nothing to disclose. A. Nair reports salary reimbursement from Biomedical Research Centre UCL, and is medical advisor to Aidence BV, outside the submitted work. P.J.M. Openshaw reports personal fees for consultancy work with Janssen, J and J and Sanofi; grants from MRC, European Union, NIHR Biomedical Research Centre and Wellcome Trust, collaborative grants with GSK, personal fees from the European Respiratory Society and an NIHR Senior Investigator Award outside the submitted work; in addition, P.J.M. Openshaw was President of the British Society for Immunology; this was an unpaid appointment but travel and accommodation at some meetings was provided by the Society. G. Parker is director and shareholder of Bioxydyn Limited, outside the submitted work. G. Reilly has nothing to disclose. G. Robinson has nothing to disclose. G. Roditi has nothing to disclose. J.C.L. Rodrigues has nothing to disclose. N. Sebire has nothing to disclose. M.G. Semple reports grants from DHSC National Institute of Health Research UK, Medical Research Council UK, Health Protection Research Unit in Emerging and Zoonotic Infections, and University of Liverpool, during the conduct of the study; and is minority owner of Integrum Scientific LLC, Greensboro, NC, USA, outside the submitted work. C. Sudlow has nothing to disclose. N. Woznitza reports grants from Cancer Research UK and Roy Castle Lung Cancer Foundation, personal fees from InHealth, outside the submitted work. I. Joshi has nothing to disclose.",
year = "2020",
month = aug,
day = "1",
doi = "10.1183/13993003.01809-2020",
language = "English",
volume = "56",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "2",
}